DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer
Jul 05, 2022, 08:30 ET CUPERTINO, Calif., July 5, 2022 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on epigenetic regulation to develop treatments for acute organ injury and chronic liver diseases, today announced the appointment of Timothy M. Papp as its Chief Financial Officer. In this new role, Mr. Papp will direct and oversee all financial […]
DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer Read More »